Towards precision medicine in atypical haemolytic uraemic syndrome 14 August 2023 New research from Professor David Kavanagh and his team in Newcastle, supported by Kidney Research UK, has shown that genetic information can help predict which patients diagnosed with atypical haemolytic uraemic syndrome (aHUS) will respond to treatment with a medication called eculizumab. This research…

Using the kidney biopsy to personalise management of atypical haemolytic uraemic syndrome 12 May 2022 With our funding, Professor David Kavanagh from Newcastle University and Professor Ian Roberts from Oxford University Hospitals will study ways to identify which kidney patients will respond to drug treatment for atypical haemolytic uremic syndrome (aHUS). Professor David Kavanagh What…